MedTrace Logo

Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood

NCT00798226 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2025-04-13

No results posted yet for this study

Summary

The aim of this study is to prevent asthma and allergies in childhood by supplementation with fish oil (n-3 fatty acids) to the mother during pregnancy. Paticipants are mother and children participating in the ABC-(Asthma Begins in Childhood)cohort. Mothers are recruited during pregnancy and receive supplement with n-3 fatty acids or olive oil (placebo) from week 24 of gestation to 1 week after delivery. The child is followed with acute and planned visit at the research unit and diagnosis of disease is done in the research unit according to predefined algorithms.

Conditions

Interventions

DIETARY_SUPPLEMENT

n-3 fatty acid

Oral intake of 4 capsules daily from week 24 of gestation to 1 week after delivery

DIETARY_SUPPLEMENT

olive oil

Oral intake of 4 capsules (1 g) daily from 24 weeks of gestation to 1 week after delivery

Sponsors & Collaborators

  • Copenhagen Studies on Asthma in Childhood

    lead OTHER

Principal Investigators

  • Klaus Bønnelykke, MD, PhD · COPSAC / University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-26
Primary Completion
2027-07-31
Completion
2027-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00798226 on ClinicalTrials.gov